Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma

NCT01555281 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
33
Enrollment
OTHER
Sponsor class

Stopped In connection with the restructuring of SAKK, older ongoing studies were analyzed to determine whether a continuation of the trial would still add value to the data analysis, or whether they do not and could therefore be prematurely terminated.

Conditions

Interventions

Sponsor

Swiss Cancer Institute